| Avery J Evans, MD | |
|
1215 Lee St, Charlottesville, VA 22908-0001 | |
| (434) 924-9400 | |
| (434) 982-1618 |
| Full Name | Avery J Evans |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 35 Years |
| Location | 1215 Lee St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841200078 | NPI | - | NPPES |
| 1841200078 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 0101051039 (Virginia) | Secondary |
| 2085N0700X | Radiology - Neuroradiology | 0101051039 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
"An international team of scientists has decoded the genome of one of the main vectors of Chagas disease, paving the way for more targeted vector control and new ways to prevent disease transmission," SciDev.Net reports.
Moving from a high-poverty to lower-poverty neighborhood spurs long-term gains in the physical and mental health of low-income adults, as well as a substantial increase in their happiness, despite not improving economic self-sufficiency, according to a new study published in the Sept. 20 issue of Science by researchers at the University of Chicago and partners at other institutions.
› Verified 2 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
"An international team of scientists has decoded the genome of one of the main vectors of Chagas disease, paving the way for more targeted vector control and new ways to prevent disease transmission," SciDev.Net reports.
Moving from a high-poverty to lower-poverty neighborhood spurs long-term gains in the physical and mental health of low-income adults, as well as a substantial increase in their happiness, despite not improving economic self-sufficiency, according to a new study published in the Sept. 20 issue of Science by researchers at the University of Chicago and partners at other institutions.
› Verified 2 days ago
| Entity Name | Bon Secours St Marys Hospital Of Richmond Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962464016 PECOS PAC ID: 8527969476 Enrollment ID: O20040324000566 |
News Archive
As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
"An international team of scientists has decoded the genome of one of the main vectors of Chagas disease, paving the way for more targeted vector control and new ways to prevent disease transmission," SciDev.Net reports.
Moving from a high-poverty to lower-poverty neighborhood spurs long-term gains in the physical and mental health of low-income adults, as well as a substantial increase in their happiness, despite not improving economic self-sufficiency, according to a new study published in the Sept. 20 issue of Science by researchers at the University of Chicago and partners at other institutions.
› Verified 2 days ago
| Entity Name | University Of Virginia Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720233596 PECOS PAC ID: 2567479405 Enrollment ID: O20090421000339 |
News Archive
As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
"An international team of scientists has decoded the genome of one of the main vectors of Chagas disease, paving the way for more targeted vector control and new ways to prevent disease transmission," SciDev.Net reports.
Moving from a high-poverty to lower-poverty neighborhood spurs long-term gains in the physical and mental health of low-income adults, as well as a substantial increase in their happiness, despite not improving economic self-sufficiency, according to a new study published in the Sept. 20 issue of Science by researchers at the University of Chicago and partners at other institutions.
› Verified 2 days ago
| Entity Name | Bon Secours Medical Group Richmond Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477112225 PECOS PAC ID: 8022440056 Enrollment ID: O20191113002170 |
News Archive
As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
"An international team of scientists has decoded the genome of one of the main vectors of Chagas disease, paving the way for more targeted vector control and new ways to prevent disease transmission," SciDev.Net reports.
Moving from a high-poverty to lower-poverty neighborhood spurs long-term gains in the physical and mental health of low-income adults, as well as a substantial increase in their happiness, despite not improving economic self-sufficiency, according to a new study published in the Sept. 20 issue of Science by researchers at the University of Chicago and partners at other institutions.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Avery J Evans, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Avery J Evans, MD 1215 Lee St, Charlottesville, VA 22908-0001 Ph: (434) 924-9400 |
News Archive
As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
"An international team of scientists has decoded the genome of one of the main vectors of Chagas disease, paving the way for more targeted vector control and new ways to prevent disease transmission," SciDev.Net reports.
Moving from a high-poverty to lower-poverty neighborhood spurs long-term gains in the physical and mental health of low-income adults, as well as a substantial increase in their happiness, despite not improving economic self-sufficiency, according to a new study published in the Sept. 20 issue of Science by researchers at the University of Chicago and partners at other institutions.
› Verified 2 days ago
Dr. Norman A. Brenbridge, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 500 Martha Jefferson Dr, Charlottesville Radiology, Charlottesville, VA 22911 Phone: 434-244-4580 Fax: 434-244-4579 | |
Gia Ann Deangelis, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St Fl 1, Charlottesville, VA 22908 Phone: 434-924-2781 Fax: 434-982-1618 | |
Dr. Akhil Khetarpal, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Box 800719, Charlottesville, VA 22908 Phone: 434-924-2150 | |
Thomas J. Druzgal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Lee St Fl 1, Charlottesville, VA 22908 Phone: 434-243-6888 Fax: 434-982-0943 | |
Rachita Khot, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 545 Ray C. Hunt Drive, Charlottesville, VA 22903 Phone: 434-982-0415 Fax: 434-243-6999 | |
Michael T. Perry, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-9400 Fax: 434-982-1618 | |
Dr. Colin P Derdeyn, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-9400 |